MRP Capital Investments’s Gilead Sciences GILD Stock Holding History

MRP Capital Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Buy	900 +100	+13%	+$13.2K	0.08%	104
2026 Q1	$111K	Hold	800	–	–	0.1%	94
2025 Q4	$98.2K	Buy	+800	New	+$97.2K	0.08%	110
2025 Q3	–	Sell	-100	Closed	-$11.1K	–	210
2025 Q2	$11.1K	Buy	+100	New	+$10.6K	0.01%	153
2025 Q1	–	Sell	-100	Closed	-$9.24K	–	223
2024 Q4	$9.24K	Buy	+100	New	+$9K	0.01%	171
2023 Q3	–	Sell	-800	Closed	-$61.7K	–	133
2023 Q2	$61.7K	Sell	800 -8,886	-92%	-$709K	0.06%	149
2023 Q1	$804K	Buy	+9,686	New	+$802K	0.88%	46

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MRP Capital Investments's GILD Position: Q2 2026 in Review

MRP Capital Investments increased its Gilead Sciences (GILD) stake by 13% in Q2 2026, buying an estimated $13.2K and bringing the position to 900 shares worth $114K. The position accounts for 0.08% of the portfolio, ranked #104.

MRP Capital Investments first reported a position in GILD in Q1 2023 and has held it in 7 quarters since. The position peaked at $804K in Q1 2023. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

MRP Capital Investments held 900 shares of Gilead Sciences worth $114K as of Q2 2026.
MRP Capital Investments bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
Gilead Sciences made up 0.08% of MRP Capital Investments's portfolio in Q2 2026, its #104 holding.
MRP Capital Investments first reported a position in Gilead Sciences in Q1 2023 and has held it in 7 quarters since.
MRP Capital Investments's Gilead Sciences position peaked at $804K in Q1 2023.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.